U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07673211) titled 'Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical Cancer' on June 23.
Brief Summary: Primary Objective of this study: To investigate the correlation between longitudinal quantitative dynamics of circulating tumor DNA (ctDNA) and HPV-derived cell-free DNA (HPV cfDNA) in peripheral blood and clinical prognosis among patients with recurrent and metastatic cervical cancer who achieved complete response following standard first-line systemic therapy.
Study Start Date: June, 2026
Study Type: OBSERVATIONAL
Condition:
Cervical Cancer
Recurrent Cervical Cancer
Metastatic Cervical Cancer
Inte...